Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.

news email 150x110

Get the Latest Genmab News

Subscribe to our email alert mailing list to ensure you receive the latest news from Genmab as it happens. Visit and fill out the form to subscribe.

Our Technologies Explained

Learn about Genmab’s proprietary cutting edge technologies, the DuoBody® and HexaBody® platforms at our new technology website

calendar 150x110

Upcoming Events

A list of investor conferences at which Genmab will present, as well as financial report dates and other events can be found on the Events & presentations page of this website.